Recruiting • Phase NA • Stage 0, I, II, III, IV • Post-Menopausal • Interventional
The following is imported from ClinicalTrials.gov:
The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.
Breast Cancer
Interventional
125 participant
November 19, 2021
18 - 999
female
GE Logiq E10 clinical ultrasound scanner
Verasonics research scanner
adult women, ≥ 18 years of age.
breast lesion and are scheduled for clinically-indicated biopsy.
< 18 years of age.
previous breast surgery or breast implant.
lacking capacity to consent.
pregnant or lactating.
receiving cancer therapy such as chemotherapy or radiation therapy.
Recruiting
125
01/10/2024
Shigao Chen, Ph.D.
Mayo Clinic
Rochester, Minnesota, United States
© 2024 Outcomes4Me Inc. All rights reserved.